相关实验视频
Updated: Sep 18, 2025

10:03
A Zebrafish Model of Diabetes Mellitus and Metabolic Memory
Published on: February 28, 2013
26.0K
我们应该治疗轻度妊娠糖尿病吗? 一项澳大利亚多中心回顾性队列研究
Victoria L Rudland1, Emily Hibbert2,3, Jeff Flack4,5,6
1Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Camperdown, Sydney, NSW, 2050, Australia. victoria.rudland@sydney.edu.au.
Acta diabetologica
|June 20, 2025
概括
治疗国际妊娠糖尿病协会研究小组 (IADPSG) 诊断的轻度妊娠糖尿病 (GDM) 标准减少了妊娠年龄婴儿的治疗标准. 然而,治疗增加了分娩诱导,强调需要小心管理轻度GDM.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 公共卫生 公共卫生
背景情况:
- 孕期糖尿病 (GDM) 诊断标准在全球范围内有所不同.
- 国际妊娠糖尿病协会研究小组 (IADPSG) 的标准在澳大利亚被广泛使用.
- 对IADPSG标准与较旧的澳大利亚糖尿病与怀孕协会1998年 (ADIPS1998) 怀孕结果标准进行比较的证据有限.
研究的目的:
- 评估治疗"轻度"GDM对怀孕结果的影响.
- "轻度"GDM被定义为满足一个,但不满足两个诊断标准.
- 为了比较治疗和不治疗轻度GDM之间的结果.
主要方法:
- 在澳大利亚悉尼 (2016-2017年) 接受了17512名孕妇的回顾性队列研究.
- 妇女使用75克口服葡萄糖耐受性测试进行查.
- 三家医院使用了ADIPS1998标准,三家医院使用了IADPSG标准进行诊断和治疗.
主要成果:
- 13.2%的女性患有"轻度"的GDM.
- 仅IADPSG的GDM的治疗与更少的妊娠年龄婴儿 (RR 0.66) 相关,但更多的分娩诱导 (RR 1.55).
- 与没有治疗相比,仅治疗ADIPS1998-GDM在怀孕结果中没有显著差异.
结论:
- 治疗轻度GDM,特别是根据IADPSG标准诊断时,可以改善特定的怀孕结果.
- 这些发现强调了管理轻度GDM的重要性,以减轻风险.
- 可能需要进一步的研究来优化不同GDM分类的治疗策略.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes: Management and Pharmacotherapy
410
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
410
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Oral Hypoglycemic Agents: Biguanides and Glitazones
310
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
310
Diabetes: Symptoms, Diagnosis, and Complications
709
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
709

